Fatima Hussain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Fatima Hussain has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
Bilal Ali
Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan
2 shared publicationsSyeda Umbreen Munir
Department of Medicine, Karachi Medical and Dental College, Karachi, Pakistan
2 shared publicationsAbdullah
1 shared publicationAbdullah Aslam Khan
Department of Medicine, Rawal Institute of Health Sciences, Islamabad, Pakistan
1 shared publicationAbeer T. M. A. Khan
Department of Medicine, Rawal Institute of Health Sciences, Islamabad, Pakistan
1 shared publicationAbeer Tahir Mehmood
Department of Medicine, Rawal Institute of Health Sciences, Islamabad, Pakistan
1 shared publication
Latest Publications
- 24 October 2025
- Published by Elsevier in American Journal of Infection Control
- Vol. 54 (3) , 260-266
Demographic and regional trends in Clostridioides difficile-related mortality among adults in the United States from 1999 to 2023
- 24 October 2025
- Published by Elsevier in American Journal of Infection Control
- Vol. 54 (3) , 260-266
Demographic and regional trends in Clostridioides difficile-related mortality among adults in the United States from 1999 to 2023
- 13 March 2025
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 25 (8) , e553-e562
Analyzing Two Decades of Leukemia Mortality in the U.S. (1999-2020)
- 13 March 2025
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 25 (8) , e553-e562
Analyzing Two Decades of Leukemia Mortality in the U.S. (1999-2020)
- 20 February 2025
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 20 (4) , 1003-1012
Demographic and regional trends in systemic and cardiovascular amyloidosis-related mortality among older adults in the United States from 1999 to 2020
Despite therapy advancements, amyloidosis mortality rates for older adults (aged ≥ 65) are rising. This study analyzes trends in amyloidosis-related mortality among older adults in the U.S. We conducted a cross-sectional analysis of death certificates from the CDC WONDER database for amyloidosis-related deaths from 1999 to 2020. Age-adjusted mortality rates (AAMRs) per 100,000 persons and annual percent change (APC) were calculated by age, race/ethnicity, urban–rural classification, and region. From 1999 to 2020, AAMR for amyloidosis in older adults (aged ≥ 65) in the U.S. increased from 2.7 to 5.6. Men consistently had higher AAMRs than women (men: 3.7 vs. women: 2.2 in 1999; men: 8.5 vs. women: 3.5 in 2020). In 2020, Non-Hispanic Blacks had the highest AAMR at 11.8, with an APC of 19.8 (95% CI 10.5–25.5). Regional differences were notable, with AAMRs highest in the Northeast (6.9) and lowest in the South (4.2). Large metropolitan areas had a higher AAMR (6.3) than non-metropolitan areas (4.6). Cardiac amyloidosis accounted for 68.8% of deaths, with AAMR rising from 1.7 to 4.2. There has been a significant increase in AAMRs for amyloidosis in the U.S. from 1999 to 2020, particularly among males, Non-Hispanic Blacks, and those in large metropolitan and Northeast areas. These findings stress the need for enhanced prevention and treatment strategies for older adults. Graphical abstract
- 20 February 2025
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 20 (4) , 1003-1012
Demographic and regional trends in systemic and cardiovascular amyloidosis-related mortality among older adults in the United States from 1999 to 2020
Despite therapy advancements, amyloidosis mortality rates for older adults (aged ≥ 65) are rising. This study analyzes trends in amyloidosis-related mortality among older adults in the U.S. We conducted a cross-sectional analysis of death certificates from the CDC WONDER database for amyloidosis-related deaths from 1999 to 2020. Age-adjusted mortality rates (AAMRs) per 100,000 persons and annual percent change (APC) were calculated by age, race/ethnicity, urban–rural classification, and region. From 1999 to 2020, AAMR for amyloidosis in older adults (aged ≥ 65) in the U.S. increased from 2.7 to 5.6. Men consistently had higher AAMRs than women (men: 3.7 vs. women: 2.2 in 1999; men: 8.5 vs. women: 3.5 in 2020). In 2020, Non-Hispanic Blacks had the highest AAMR at 11.8, with an APC of 19.8 (95% CI 10.5–25.5). Regional differences were notable, with AAMRs highest in the Northeast (6.9) and lowest in the South (4.2). Large metropolitan areas had a higher AAMR (6.3) than non-metropolitan areas (4.6). Cardiac amyloidosis accounted for 68.8% of deaths, with AAMR rising from 1.7 to 4.2. There has been a significant increase in AAMRs for amyloidosis in the U.S. from 1999 to 2020, particularly among males, Non-Hispanic Blacks, and those in large metropolitan and Northeast areas. These findings stress the need for enhanced prevention and treatment strategies for older adults. Graphical abstract